Skip to main content
. 2009 Aug 31;27(28):4727–4732. doi: 10.1200/JCO.2008.21.4197

Fig 3.

Fig 3.

Overall survival estimates adjusted for Zubrod performance status, high-risk group (ie, extracapsular extension, positive margins), and primary tumor site among patients in this study (ie, Radiation Therapy Oncology Group [RTOG] 0024) compared with those in the radiation therapy (RT) plus chemotherapy (CT) group of RTOG 9501.